ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
-0,04%
Bitcoin
63.277,95
0,12%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aeterna Zentaris Inc (AEZS)

  7. Aeterna Zentaris Inc (AEZS) News

AEZS

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AEZS
DatumZeitQuelleÜberschriftSymbolFirma
27/08/202413h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
07/08/202400h00GlobeNewswire Inc.Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.NASDAQ:AEZSAeterna Zentaris Inc
16/07/202422h05GlobeNewswire Inc.Aeterna Zentaris Announces Results of Virtual 2024 Meeting of ShareholdersNASDAQ:AEZSAeterna Zentaris Inc
13/06/202415h20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
13/06/202415h10GlobeNewswire Inc.Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
10/06/202419h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
06/06/202419h46Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AEZSAeterna Zentaris Inc
05/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEZSAeterna Zentaris Inc
05/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEZSAeterna Zentaris Inc
05/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEZSAeterna Zentaris Inc
03/06/202415h15GlobeNewswire Inc.Aeterna Zentaris and Ceapro Complete Merger TransactionNASDAQ:AEZSAeterna Zentaris Inc
03/06/202415h15GlobeNewswire Inc.Aeterna Zentaris and Ceapro Complete Merger TransactionNASDAQ:AEZSAeterna Zentaris Inc
31/05/202403h58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AEZSAeterna Zentaris Inc
31/05/202403h56Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEZSAeterna Zentaris Inc
31/05/202403h56Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEZSAeterna Zentaris Inc
31/05/202403h55Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEZSAeterna Zentaris Inc
30/05/202403h31Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:AEZSAeterna Zentaris Inc
30/05/202400h35GlobeNewswire Inc.Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption DateNASDAQ:AEZSAeterna Zentaris Inc
17/05/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:AEZSAeterna Zentaris Inc
17/05/202414h00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:AEZSAeterna Zentaris Inc
17/05/202414h00GlobeNewswire Inc.Aeterna Zentaris Announces Details Regarding Transaction with CeaproNASDAQ:AEZSAeterna Zentaris Inc
17/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEZSAeterna Zentaris Inc
17/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEZSAeterna Zentaris Inc
15/05/202400h00GlobeNewswire Inc.Aeterna Zentaris Reports First Quarter 2024 Financial ResultsNASDAQ:AEZSAeterna Zentaris Inc
01/05/202413h55GlobeNewswire Inc.Aeterna Zentaris Announces Effective Date of Share ConsolidationNASDAQ:AEZSAeterna Zentaris Inc
28/03/202412h55GlobeNewswire Inc.Ceapro Receives Final Court Approval for Merger with Aeterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
28/03/202412h55GlobeNewswire Inc.Ceapro Receives Final Court Approval for Merger with Aeterna ZentarisNASDAQ:AEZSAeterna Zentaris Inc
27/03/202413h05GlobeNewswire Inc.Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone DeficiencyNASDAQ:AEZSAeterna Zentaris Inc
12/03/202419h10GlobeNewswire Inc.Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsNASDAQ:AEZSAeterna Zentaris Inc
12/03/202419h10GlobeNewswire Inc.Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special MeetingsNASDAQ:AEZSAeterna Zentaris Inc
 Showing the most relevant articles for your search:NASDAQ:AEZS

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
NYSE
XOM
Exxon Mobil
DBI
SDXP
SDAX
CCOM
US500
US 500
TG
BAS
BASF
NYSE
MCD
McDonalds
CCOM
US100
US Tech 100
TG
MBG
MercedesBenz
AMEX
SPY
SPDR S&P 500
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
TG
CBK
Commerzbank
TG
LHA
Deutsche Lufthansa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten